Synergic effect of anticancer peptide CIGB-552 and Cisplatin in lung cancer models.
Yolanda Gomez RodriguezBrizaida Oliva ArguellesMario Riera RomoJorge Fernandez-De-CossioHilda Elisa GarayJulio Raúl Fernández MassóMaribel Guerra VallespiPublished in: Molecular biology reports (2022)
These findings demonstrate the efficacy of the concomitant combination of both drugs in preclinical studies and support the use of this therapy in clinical trials. This study is the first evidence of synergistic effect of the combination of the antitumoral peptide CIGB-552 and CDDP.